BMO Capital Downgrades Marchex To Market Perform

Analysts at BMO Capital downgraded Marchex

from Outperform to Market Perform. The target price for Marchex has been lowered from $14 to $5. Marchex shares have declined 44.85% over the past 52 weeks, while the S&P 500 index has surged 17.63% in the same period. Marchex's shares dipped 45.73% to closed at $4.07 yesterday.